Friday, July 21, 2023 12:38:15 PM
REPORT #27 (2023) For Week Ending 7/14/2023.
Thanks once again to @rafunrafun for providing the script data.
The Takeaway:
• VASCEPA® Total scripts 63,084 (+5796), 2nd best this year.
• Total Market Scripts (177,657), All Time High
• VASCEPA® Market Share this week: 57.56% vs generic VASCEPA® (Same as last week)
• VASCEPA® Market share vs. Generic Lovaza remains the same (48.4% vs. 51.6%)
You can find this week’s Report (07/07/2023) here.
https://drive.google.com/file/d/1MkyJpo1DMYG6ygPXUsD1niuznF-KsX7G/view?usp=sharing
Recent AMRN News
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
